Review of main haemovigilance systems in the world;Revue des principaux systèmes d'hémovigilance dans le monde

Transfusion Clinique et Biologique

Volumn 16, Issue 2, 2009, Pages 86-92

  Faber, J C ^a  

^a ConsulTrans Général ^*  (Luxembourg)

Author keywords

Adverse events; Adverse reactions; Donors; Haemovigilance; Quality improvement; Recipients; Surveillance; Systems; Transfusion chain

Indexed keywords

ALERTNESS; ATTITUDE TO HEALTH; BLOOD COMPONENT THERAPY; BLOOD DONOR; BLOOD TRANSFUSION REACTION; ECONOMIC ASPECT; EUROPE; EUROPEAN UNION; HEALTH CARE SYSTEM; HUMAN; MANDATORY PROGRAM; MEDICAL SOCIETY; RECIPIENT; SAFETY; SHORT SURVEY; TOTAL QUALITY MANAGEMENT;

BLOOD TRANSFUSION; EUROPEAN UNION; HUMANS; RISK MANAGEMENT; SAFETY MANAGEMENT;

EID: 67349193781     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2009.03.001     Document Type: Short Survey

References (10)

1. Engelfriet C.P., and Reesink H.W. Haemovigilance systems. Vox Sang 77 (1999) 110-120
2. Faber J.C. L'hémovigilance en Europe. Transfus Clin Biol 7 (2000) 5-8
3. Faber J.C. Haemovigilance: definition and overview of current haemovigilance systems. TATM 5 1 (2003) 237-245
4. Faber J.C. Haemovigilance around the world. Vox Sang 83 Suppl. 1 (2002) 071-076
5. Faber JC. Compilation of European data in haemovigilance; 5th EHS (European Haemovigilance Seminar), Amsterdam; 2003 [Abstract book].
6. Faber JC. Basic clinical and organisational requirements for an effective haemovigilance; ESTM (European School for Transfusion Medicine) Residential Course, Sofia, Bulgaria, 2002.
7. Williamson L.M. Transfusion hazard reporting: powerful data, but do we know how best to use it?. Transfusion 42 (2002) 1249-1252 [Editorial]
8. Afssaps, Agence française de sécurité sanitaire des produits de santé: rapport 2006.
9. National Haemovigilance Office, Ireland: Annual Report 2006.
10. TRIP Office, Netherlands: Report 2006.